Perspective Therapeutics, Inc. (CATX)
1.155
-0.10
(-7.60%)
USD |
NYAM |
Oct 29, 16:00
1.155
0.00 (0.00%)
After-Hours: 19:05
Perspective Therapeutics Price : 1.155 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 1.21 | 1.25 | 1.065 | 1.25 | 4.593M |
| Oct 27, 2026 | 1.20 | 1.26 | 1.06 | 1.19 | 8.739M |
| Oct 26, 2026 | 1.40 | 1.591 | 1.115 | 1.21 | 9.623M |
| Oct 23, 2026 | 2.40 | 2.40 | 1.58 | 1.61 | 5.614M |
| Oct 22, 2026 | 2.25 | 2.335 | 2.22 | 2.26 | 967762.0 |
| Oct 21, 2026 | 2.32 | 2.365 | 2.275 | 2.30 | 1.241M |
| Oct 20, 2026 | 2.19 | 2.37 | 2.19 | 2.30 | 1.813M |
| Oct 19, 2026 | 2.20 | 2.249 | 2.15 | 2.19 | 1.139M |
| Oct 16, 2026 | 2.34 | 2.34 | 2.15 | 2.17 | 1.670M |
| Oct 15, 2026 | 2.27 | 2.37 | 2.23 | 2.34 | 1.190M |
| Oct 14, 2026 | 2.36 | 2.36 | 2.21 | 2.24 | 1.394M |
| Oct 13, 2026 | 2.50 | 2.52 | 2.25 | 2.27 | 1.310M |
| Oct 12, 2026 | 2.61 | 2.67 | 2.505 | 2.52 | 640582.0 |
| Oct 09, 2026 | 2.71 | 2.755 | 2.625 | 2.66 | 1.105M |
| Oct 08, 2026 | 2.43 | 2.73 | 2.37 | 2.71 | 3.255M |
| Oct 07, 2026 | 2.37 | 2.51 | 2.322 | 2.46 | 1.286M |
| Oct 06, 2026 | 2.59 | 2.60 | 2.30 | 2.36 | 2.703M |
| Oct 05, 2026 | 2.75 | 2.82 | 2.48 | 2.57 | 3.561M |
| Oct 02, 2026 | 2.77 | 2.82 | 2.685 | 2.76 | 2.622M |
| Oct 01, 2026 | 2.71 | 2.775 | 2.66 | 2.72 | 1.543M |
| Sep 30, 2026 | 2.64 | 2.775 | 2.55 | 2.75 | 1.670M |
| Sep 29, 2026 | 2.52 | 2.62 | 2.49 | 2.62 | 1.542M |
| Sep 28, 2026 | 2.50 | 2.575 | 2.46 | 2.50 | 1.505M |
| Sep 25, 2026 | 2.50 | 2.525 | 2.45 | 2.52 | 1.802M |
| Sep 24, 2026 | 2.58 | 2.59 | 2.44 | 2.50 | 1.698M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 21.77 |
| MiMedx Group, Inc. | 3.97 |
| ABVC BioPharma, Inc. | 1.05 |
| Enovis Corp. | 22.79 |
| Edwards Lifesciences Corp. | 94.37 |
Price Related Metrics
| PS Ratio | 263.26 |
| PEG Ratio | -2.091 |
| Price to Book Value | 0.4068 |
| Earnings Yield | -115.0% |
| Market Cap | 131.77M |
| PEGY Ratio | -2.091 |